| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.0055 | 1 |